Our Vision

Scopio is changing the standard of healthcare and revolutionizing first-line diagnostic testing by harnessing the power of computational photography and AI to image and analyze the morphology of cells at a scale that was never possible before, expediting access to life-saving treatments and improved patient outcomes.

Our Story

Scopio Labs was founded by two physicists and visionaries determined to push the boundaries of medicine and innovate in a way that would do some good in the world.

Early in their careers, Itai Hayut and Erez Na’aman dreamed of a collaboration. After witnessing medical practitioners in the hematology lab who still rely on analog, outdated, and labor-intensive practices using traditional microscopes and manual cell counts, they realized that with their backgrounds in physics, IT and medical device technology and the evolution of deep learning, they could use AI-powered analysis to bring microscopy and hematology into the digital age. All they needed was to find a scanner to digitize the slides, and the rest would fall into place.

But no such scanner existed, and so that’s where the Scopio story began.

The result is a series of innovations that brings high-quality data and advancements in deep learning to the practice of hematology, transforming the future of disease detection and diagnosis forever.

Leadership

Itai Hayut

Co-Founder and CEO

Erez Na'aman

Co-Founder and CTO

Guy Nathanzon

CFO

Iris Getz

CSO

Eran Small PhD

SVP R&D

Shahar Karny

COO

Amy Meitus MD

VP Product

Ben Leshem PhD

VP Imaging & Research

Tom Millonig

VP Global Hematology Sales

Lianne Trantz

VP Marketing

Meet the Scopio Team

Roni Agami

Ofek Aizenman

Tomer Atar

Ricky Avissara

Hadas Avraham

Itay Avrahami

Niv Baehr

Itamar Beeri

Shaked Ben Baruch

Adir Ben-Avi

Eyal Ben-Bassat

Ilan Bleyhman

Itay Bracha

Yonatan Caimowitz

Doron Cohen

Tali Cohen

Yoav Cohen

Eliya Danino

Tomer Diament

Kaydan Giladi

Kosta Gorodetsky

Omri Gropper

Yossi Hananya

Amit Hauzer

Yossi Hayat

Mickey Iluz

Ram Keidar

Yadin Kulp

Netanel Lanzkron

Dana Lazarian

Nadav Levi

Osher Levi

Ittai Madar

Amit Natan

Hila Prat

Dennis Ratzker

Ifat Raved

Roy Sarafov

Tal Sarid

Ben Sarusi

Chen Sasson

Ran Scheiner

Ofer Schwartz

Kim Sela

Adam Shafir

Amir Shaham

Danna Shaham

Mira Shem Tov

Hadar Shimoni

Denis Stepanov

Shahar Weil

Tal Yakir

Yaron Yaskerovitch

Bar Zelingher

Maxim Zheltobrukhov

Eran Zilkha

Press

Corporate Announcements

June 9, 2022: Scopio Labs Awarded FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization. This is the company’s second FDA clearance, broadening its suite of fully digital platforms to cater to all lab sizes and networks

Feb 9, 2022: Scopio raises $50M to take a deeper look into our blood cells. The company’s ultra high quality and FDA-cleared imaging and AI analysis platforms enhance diagnostic capabilities and enable remote work

Sept 27, 2021: Scopio Labs Launches Full-Field Peripheral Blood Smear Application, Bringing End-to-End Digital Workflow to Hematology Labs to Transform Diagnostic Testing

Oct 21, 2020: FDA Clearance of Full Field PBS Application. The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics

Apr. 28, 2020: Scopio Labs Closes $16 Million Series B Round to Expand Commercial Rollout of Automated Microscopy Solutions. All-Digital AI-Powered Platform to Reduce Human Error, Connect Remote Experts, Increase Diagnostic Lab Reliability and Efficiency

Apr. 13, 2020: Scopio Labs Receives CE Mark for X100 Microscope and Decision Support System With Full Field Peripheral Blood Smear (PBS) Application. All-Digital Automated Scanning and AI-Powered Analysis Enables Precise and Comprehensive Diagnosis, Remote Consultation and Accelerated Results to Improve Care Outcomes